Special
Opportunities for Patient Representatives
Patient Advocate Fellowship Program:
Do you represent a 501(c)(3) organization in the United States or registered
charities in Canada that serve constituents with:
• Major chronic
diseases; and/or
• Rare/ Orphan diseases?
Then you can’t afford to miss your opportunity to apply for a scholarship to
attend the DIA
2013 49th Annual Meeting as part of the Patient
Advocate Fellowship Program.
20 patient representatives, chosen through a competitive process, will have
opportunities to develop, strengthen, and support collaborations with
policymakers, industry, academia, and health professionals by taking part in all
facets of DIA 2013 49th Annual Meeting.
Deadline for Applications: Friday, February 1, 2013
What is the Patient Advocate Fellowship Program?
The DIA Patient Advocate Fellowship
Program is designed to:
• Develop, strengthen, and support patient
collaborations with policy makers, health
professionals, industry
representatives, and academia
• Increase the knowledge and understanding
of patient groups about key issues
central to patient-centered health
care, biomedical research, and drug development
• Develop the capacity
of patient groups to advocate for change
• Improve alliances between
patient groups and other health care stakeholders
• Stimulate
cooperation, promote dialogue, and share best practices
DIA 2012 48th Annual Meeting Participating Organizations:
ARPKD/CHF Alliance, Averys Angels Gastroschisis Foundation, Canadian Organization for Rare Disorders, Cholangiocarcinoma Foundation, HepTREC, Huntington's Disease Society of America, International Cancer Advocacy Network, International WAGR Syndrome Association, Lupus Foundation of America, Mass General Cancer Center, Mastocytosis Society, MRSA Survivors Network, National Alliance for Medication Assisted Recovery, National Dysautonomia Research Foundation, Nueva Vida (Latin Women with Cancer), Ovarian Cancer National Alliance, Soft Bones, Sturge-Weber Foundation, United Nations Bone and Joint Decade, Vestibular Disorders Association
What is the DIA 2013 49th Annual Meeting?
DIA
2013 49th Annual Meeting connects all partners involved in bringing new
therapies to patients. Historically, this enterprise has focused on drug
development, but today those partners include a very diverse range of
stakeholders from biotechnology, diagnostics, and medical device companies, to
regulatory agencies, scientific and academic communities, service payers and
providers, and patient organizations. See
for Yourself...
Global Patient
Initiatives
Patient organizations are key players in DIA’s
mission to foster innovation to improve health and well-being worldwide. Find
out how you can make an impact as a patient group representative.
Special Discount for Patient Organizations:
DIA offers another opportunity for patient organizations at
the Annual Meeting by offering registration
for only $250, which includes a
one-year complimentary e-membership. Proof of 501 c3 status required. Download the registration form.
Just Released! Keynote Speaker:
Daniel
Kraft, MD
Executive Director,
FutureMed
Hear
from Dr. Kraft regarding the DIA 2013 49th Annual Meeting
|
Mary P. Sundeen, President, HealthWell Foundation
Copayment foundations have helped hundreds of thousands of insured Americans afford their coverage and their treatments. The HealthWell Foundation, one of the nation’s largest non-profits, recently issued a white paper on copayment assistance as a primer for pharmaceutical and biotechnology personnel. Our goal is to assist with reducing a manufacturer’s exposure to legal pitfalls and to maximize their charitable donation.
Mary P. Sundeen, President, HealthWell Foundation